{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:41:58Z","timestamp":1791985318705,"version":"4.4.0"},"reference-count":64,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cent Nerv Syst Dis"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:p>\n                    Nowadays, new schizophrenia treatments are more ambitious than ever, aiming not only to improve psychotic symptoms, but also quality of life and social reinsertion. Our objective is to briefly but critically review the diagnosis of schizophrenia, the atypical antipsychotics sertindole's pharmacology, safety and status, and mainly evaluate the effects of sertindole compared with other second generation antipsychotics for people with schizophrenia and schizophrenia-like psychosis. In vitro studies showed that sertindole exerts a potent antagonism at serotonin 5-HT\n                    <jats:sub>2A<\/jats:sub>\n                    , 5-HT\n                    <jats:sub>2C<\/jats:sub>\n                    , dopamine D\n                    <jats:sub>2<\/jats:sub>\n                    , and \u03b1\n                    <jats:sub>l<\/jats:sub>\n                    adrenergic receptors. Sertindole offers an alternative treatment option for refractory patients given its good EPS profile, favorable metabolic profile, and comparable efficacy to risperidone. Due to cardiovascular safety concerns, sertindole is available as a second-line choice for patients intolerant to other antipsychotic agents. Further clinical studies, mainly comparisons with other second-generation antipsychotic agents, are needed to define the role of sertindole in the treatment of schizophrenia.\n                  <\/jats:p>","DOI":"10.4137\/jcnsd.s5729","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T18:53:51Z","timestamp":1305658431000},"page":"JCNSD.S5729","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":12,"title":["Sertindole in the Management of Schizophrenia"],"prefix":"10.4137","volume":"3","author":[{"given":"Mario F.","family":"Juruena","sequence":"first","affiliation":[{"name":"Stress and Affective Disorders Programme, Department of Neuroscience and Behaviour, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ponde00C9; De Sena","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Health Sciences, Federal University of Bahia, Salvador, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irismar","family":"Reis De Oliveira","sequence":"additional","affiliation":[{"name":"Department of Neurosciences and Mental Health, School of Medicine, Federal University of Bahia, Salvador, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2011,5,17]]},"reference":[{"key":"bibr1-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2006.00784.x"},{"key":"bibr2-JCNSD.S5729","first-page":"1","volume-title":"Comprehensive care of schizophrenia: a textbook of clinical management","author":"Wyatt RJ","year":"2001"},{"key":"bibr3-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S6226"},{"key":"bibr4-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245618"},{"key":"bibr5-JCNSD.S5729","volume-title":"Measurement and classification of psychiatric symptoms: an instructional manual for the PSE and catego program","author":"Wing JK","year":"1974"},{"key":"bibr6-JCNSD.S5729","volume-title":"Psychiatric diagnosis in New York and London","author":"Cooper JE","year":"1972"},{"key":"bibr7-JCNSD.S5729","volume-title":"APA Diagnostic and statistical manual of mental disorder","author":"(DSM-III)","year":"1980","edition":"3"},{"key":"bibr8-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750190059011"},{"key":"bibr9-JCNSD.S5729","volume-title":"APA Diagnostic and statistical manual of mental disorder","author":"(DSM-IV)","year":"1994","edition":"4"},{"key":"bibr10-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.280.6207.66"},{"key":"bibr11-JCNSD.S5729","first-page":"322","volume":"50","author":"Kane JM","year":"1989","journal-title":"Journal of Clinical Psychiatry"},{"key":"bibr12-JCNSD.S5729","first-page":"775","volume-title":"Neuropsy chopharmacology: the fifth generation of progress","author":"Miyamoto S","year":"2002"},{"key":"bibr13-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300837"},{"key":"bibr14-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2003.09.010"},{"key":"bibr15-JCNSD.S5729","first-page":"59","volume-title":"Comprehensive care of schizophrenia: a text book of clinical management","author":"Siegfried SL","year":"2001"},{"key":"bibr16-JCNSD.S5729","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0022-3565(25)23800-9","volume":"271","author":"Robertson GS","year":"1994","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"bibr17-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200012000-00022"},{"key":"bibr18-JCNSD.S5729","first-page":"1277","volume-title":"Psychopharmacology: the fourth generation of progress","author":"Meltzer HY","year":"1995"},{"key":"bibr19-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462000000500013"},{"key":"bibr20-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7273.1371"},{"key":"bibr21-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.1.13"},{"key":"bibr22-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.2.141"},{"key":"bibr23-JCNSD.S5729","first-page":"7","volume":"22","author":"Kane JM","year":"1996","journal-title":"Encephale"},{"key":"bibr24-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"},{"key":"bibr25-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.7.13.1739"},{"key":"bibr26-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.1.19"},{"key":"bibr27-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1002\/pds.848"},{"issue":"2","key":"bibr28-JCNSD.S5729","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3565(24)37654-2","volume":"286","author":"Rampe D","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr30-JCNSD.S5729","author":"Moore N","year":"1999","journal-title":"15 International Conference on Pharmacoepidemiology"},{"key":"bibr31-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199803003-00005"},{"key":"bibr32-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.1.64"},{"key":"bibr33-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1177\/026988110101500212"},{"key":"bibr34-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1080\/13651500210340"},{"key":"bibr35-JCNSD.S5729","first-page":"1825","author":"Lindstrom E","year":"2006","journal-title":"Exp Opin Drug Saf"},{"key":"bibr36-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.430220306"},{"key":"bibr37-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1007\/BF01245352"},{"key":"bibr38-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.430220306"},{"key":"bibr39-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90067-G"},{"key":"bibr40-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890100105"},{"key":"bibr41-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-081X(199708)18:6<533::AID-BDD42>3.0.CO;2-J"},{"key":"bibr42-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90063-1"},{"key":"bibr43-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050278"},{"key":"bibr44-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1021\/js970446m"},{"key":"bibr45-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04287.x"},{"key":"bibr46-JCNSD.S5729","unstructured":"H. Lundbeck A\/S. Serdolect (sertindole) monograph. Copenhagen: H. Lundbeck A\/S 2005 Sep."},{"key":"bibr47-JCNSD.S5729","first-page":"187","volume":"4","author":"Muscatello MRA","year":"2010","journal-title":"Drug Design Development and Therapy"},{"key":"bibr48-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245618"},{"key":"bibr49-JCNSD.S5729","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/13651500050518406","volume":"4","author":"Zimbroff A","year":"2000","journal-title":"Int J Psychiatry Clin Pract"},{"key":"bibr50-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1080\/13651500050518406"},{"key":"bibr51-JCNSD.S5729","first-page":"61","volume":"34","author":"Daniel DG","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"bibr52-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000177020.26311.a7"},{"key":"bibr53-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61764-X"},{"key":"bibr54-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00105-4"},{"key":"bibr55-JCNSD.S5729","author":"Kane JM","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"bibr56-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418002-00003"},{"key":"bibr57-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2004.10.020"},{"key":"bibr58-JCNSD.S5729","first-page":"CD001715","volume":"3","author":"Lewis R","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr59-JCNSD.S5729","first-page":"S422","volume":"7","author":"Kasper S","year":"2004","journal-title":"Int J Neuropsychopharmacology"},{"key":"bibr60-JCNSD.S5729","first-page":"S207","volume":"7","author":"Mack R","year":"1997","journal-title":"Eur Neuropsychopharmacology"},{"key":"bibr61-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2004.03.016"},{"key":"bibr62-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000104913.75206.62"},{"key":"bibr63-JCNSD.S5729","first-page":"266","volume":"28","author":"Misdrahi D","year":"2002","journal-title":"Encephale"},{"key":"bibr64-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199803003-00002"},{"key":"bibr65-JCNSD.S5729","doi-asserted-by":"publisher","DOI":"10.1007\/BF01245352"}],"container-title":["Journal of Central Nervous System Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.4137\/JCNSD.S5729","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.4137\/JCNSD.S5729","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.4137\/JCNSD.S5729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:00:03Z","timestamp":1777392003000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.4137\/JCNSD.S5729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":64,"alternative-id":["10.4137\/JCNSD.S5729"],"URL":"https:\/\/doi.org\/10.4137\/jcnsd.s5729","relation":{},"ISSN":["1179-5735","1179-5735"],"issn-type":[{"value":"1179-5735","type":"print"},{"value":"1179-5735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}